Titre
Nouveaux traitements biologiques et synthétiques de fond pour les spondylarthropathies [New synthetic and biologic treatments for spondylarthritis]
Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Zufferey, P.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1660-9379
Statut éditorial
Publié
Date de publication
2016-03-09
Volume
12
Numéro
509
Première page
512
Peer-reviewed
Oui
Langue
français
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
The only biological treatments recognized and reimbursed for spondylarthritis in Switzerland are anti TNF. Other effective agents in rheumatoid arthritis were found to be of little use in this indication. Fortunately, in recent years appeared biological molecules blocking cytokines involved in new pathways of inflammation in particular that of IL7. They have been very effective against psoriasis and have a high potential in psoriatic arthritis and spondylarthritis. In parallel, synthetic small molecules capable of modulating the production of intracellular cytokines begin to be marketed. They also are potentially active in the same rheumatic diseases. The purpose of this article is to review these new drugs, in particular to review the progress of their development and commercialization status.
PID Serval
serval:BIB_78A8D7BF0493
PMID
Date de création
2017-02-10T14:00:41.633Z
Date de création dans IRIS
2025-05-21T04:14:04Z
Fichier(s)![Vignette d'image]()
En cours de chargement...
Nom
RMS_509_512.pdf
Version du manuscrit
published
Licence
https://creativecommons.org/licenses/by-nc-nd/4.0
Taille
1.73 MB
Format
Adobe PDF
PID Serval
serval:BIB_78A8D7BF0493.P001
URN
urn:nbn:ch:serval-BIB_78A8D7BF04938
Somme de contrôle
(MD5):be1229f52ea0b4eb185203fe7128688a